| K-number | K032254 |
| Device name | IBL C1Q-CIC CIA TEST |
| Applicant | Ibl GmbH |
| Product code | DAK |
| Device class | Class II |
| Decision date | Aug 29, 2003 |
| Decision | Substantially Equivalent |
| Regulation | 866.5240 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov